[go: up one dir, main page]

SE9802546D0 - Medicinal product and method for treatment and prevention of dyskinesia - Google Patents

Medicinal product and method for treatment and prevention of dyskinesia

Info

Publication number
SE9802546D0
SE9802546D0 SE9802546A SE9802546A SE9802546D0 SE 9802546 D0 SE9802546 D0 SE 9802546D0 SE 9802546 A SE9802546 A SE 9802546A SE 9802546 A SE9802546 A SE 9802546A SE 9802546 D0 SE9802546 D0 SE 9802546D0
Authority
SE
Sweden
Prior art keywords
dyskinesia
prevention
treatment
medicinal product
dystonia
Prior art date
Application number
SE9802546A
Other languages
English (en)
Swedish (sv)
Inventor
Ross Nicholas Waters
Arvid Carlsson
Clas Aake Sonesson
Joakim Tedroff
Original Assignee
Ross Nicholas Waters
Arvid Carlsson
Clas Aake Sonesson
Joakim Tedroff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ross Nicholas Waters, Arvid Carlsson, Clas Aake Sonesson, Joakim Tedroff filed Critical Ross Nicholas Waters
Priority to SE9802546A priority Critical patent/SE9802546D0/xx
Publication of SE9802546D0 publication Critical patent/SE9802546D0/xx
Priority to PCT/SE1999/001274 priority patent/WO2000003714A1/fr
Priority to BR9912051-8A priority patent/BR9912051A/pt
Priority to CA002336998A priority patent/CA2336998A1/fr
Priority to JP2000559849A priority patent/JP2002520361A/ja
Priority to EP99940783A priority patent/EP1096935A1/fr
Priority to AU54568/99A priority patent/AU5456899A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE9802546A 1998-07-15 1998-07-15 Medicinal product and method for treatment and prevention of dyskinesia SE9802546D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9802546A SE9802546D0 (sv) 1998-07-15 1998-07-15 Medicinal product and method for treatment and prevention of dyskinesia
PCT/SE1999/001274 WO2000003714A1 (fr) 1998-07-15 1999-07-15 Produit medicinal et procede de traitement et de prevention de la dyskinesie
BR9912051-8A BR9912051A (pt) 1998-07-15 1999-07-15 Uso de composto, e, processo para tratamento e prevenção de discinesia.
CA002336998A CA2336998A1 (fr) 1998-07-15 1999-07-15 Produit medicinal et procede de traitement et de prevention de la dyskinesie
JP2000559849A JP2002520361A (ja) 1998-07-15 1999-07-15 運動異常を処置、保護および予防するための薬用物質および方法
EP99940783A EP1096935A1 (fr) 1998-07-15 1999-07-15 Produit medicinal et procede de traitement et de prevention de la dyskinesie
AU54568/99A AU5456899A (en) 1998-07-15 1999-07-15 Medicinal product and method for treatment and prevention of dyskinesia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802546A SE9802546D0 (sv) 1998-07-15 1998-07-15 Medicinal product and method for treatment and prevention of dyskinesia

Publications (1)

Publication Number Publication Date
SE9802546D0 true SE9802546D0 (sv) 1998-07-15

Family

ID=20412091

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9802546A SE9802546D0 (sv) 1998-07-15 1998-07-15 Medicinal product and method for treatment and prevention of dyskinesia

Country Status (7)

Country Link
EP (1) EP1096935A1 (fr)
JP (1) JP2002520361A (fr)
AU (1) AU5456899A (fr)
BR (1) BR9912051A (fr)
CA (1) CA2336998A1 (fr)
SE (1) SE9802546D0 (fr)
WO (1) WO2000003714A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
GB0002100D0 (en) 2000-01-28 2000-03-22 Novartis Ag Organic compounds
WO2002056745A2 (fr) * 2000-10-12 2002-07-25 Pharmacia & Upjohn Company Methode de traitement de la maladie de parkinson
AR031152A1 (es) * 2000-10-31 2003-09-10 Upjohn Co Tratamientos nuevos para el sindrome de piernas inquietas
US6670378B2 (en) * 2001-05-08 2003-12-30 Pharmacia & Upjohn Company Method of treating Parkinson's disease
US20130197032A1 (en) * 2010-09-20 2013-08-01 A. Carlsson Research Ab Phenylpiperidine compounds for the treatment of neurological and psychiatric disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070247D1 (en) * 1979-12-05 1985-04-04 Astra Laekemedel Ab New phenyl-azacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds
US4937346A (en) * 1979-12-05 1990-06-26 Per Arvid Emil Carlsson Phenyl-azacykloalkanes
US4719219A (en) * 1982-03-30 1988-01-12 Per A. E. Carlsson Phenyl-azacycloalkanes and use thereof in treatment of central nervous system disorders

Also Published As

Publication number Publication date
AU5456899A (en) 2000-02-07
BR9912051A (pt) 2001-04-03
EP1096935A1 (fr) 2001-05-09
WO2000003714A1 (fr) 2000-01-27
JP2002520361A (ja) 2002-07-09
CA2336998A1 (fr) 2000-01-27

Similar Documents

Publication Publication Date Title
MY140525A (en) Pharmaceutical uses for alpha2delta ligands
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
HU9603433D0 (en) Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof
EP0282959A3 (fr) 9-Amino-tétrahydro-acridines substitués et composés apparentés, leur procédé de préparation et leur utilisation comme médicaments
EP0970954A4 (fr) Derives du 3-piperidyl-4-oxoquinazoline et compositions medicinales les contenant
CA2328780A1 (fr) Dihydropyrimidines
HUP9802762A2 (hu) Difenil-metilén-piperidin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
TWI265929B (en) Triazinyl derivatives for inhibiting the production of IL-12
RU94036772A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза
HUP9900851A2 (hu) Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására
RU94044453A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей
WO1999012532A3 (fr) Derives de piperidine contre la malaria
NO944915L (no) Öking av trombomodulinekspresjon
SE9802546D0 (sv) Medicinal product and method for treatment and prevention of dyskinesia
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
HU910784D0 (en) Process for producing new urea derivatives as well as pharmaceutical preparatives containing these compounds as active substance
CA2347939A1 (fr) Composition pour le traitement du rhumatisme, de l'hepatite ou de la pancreatite
AU6257396A (en) Tetrahydrofuran antifungals
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
ATE267832T1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
NO20003138L (no) Ny anvendelse av lokalanestetika mot vaskulære hodepiner
AU2002212241A1 (en) Method for producing chiral compounds
ZA961044B (en) New pyridine and pyridazine derivatives, processes for the production thereof and pharmaceutical agents containing these compounds.
CA2187402A1 (fr) Derives de la quinoxaline pour le traitement des acouphenes
CA2147264A1 (fr) Derives de la vitamine d et methode de preparation